Nunez-Torres, R.; Pita, G.; Peña-Chilet, M.; López-López, D.; Zamora, J.; Roldán, G.; Herráez, B.; Álvarez, N.; Alonso, M.R.; Dopazo, J.;
et al. A Comprehensive Analysis of 21 Actionable Pharmacogenes in the Spanish Population: From Genetic Characterisation to Clinical Impact. Pharmaceutics 2023, 15, 1286.
https://doi.org/10.3390/pharmaceutics15041286
AMA Style
Nunez-Torres R, Pita G, Peña-Chilet M, López-López D, Zamora J, Roldán G, Herráez B, Álvarez N, Alonso MR, Dopazo J,
et al. A Comprehensive Analysis of 21 Actionable Pharmacogenes in the Spanish Population: From Genetic Characterisation to Clinical Impact. Pharmaceutics. 2023; 15(4):1286.
https://doi.org/10.3390/pharmaceutics15041286
Chicago/Turabian Style
Nunez-Torres, Rocio, Guillermo Pita, María Peña-Chilet, Daniel López-López, Jorge Zamora, Gema Roldán, Belén Herráez, Nuria Álvarez, María Rosario Alonso, Joaquín Dopazo,
and et al. 2023. "A Comprehensive Analysis of 21 Actionable Pharmacogenes in the Spanish Population: From Genetic Characterisation to Clinical Impact" Pharmaceutics 15, no. 4: 1286.
https://doi.org/10.3390/pharmaceutics15041286
APA Style
Nunez-Torres, R., Pita, G., Peña-Chilet, M., López-López, D., Zamora, J., Roldán, G., Herráez, B., Álvarez, N., Alonso, M. R., Dopazo, J., & Gonzalez-Neira, A.
(2023). A Comprehensive Analysis of 21 Actionable Pharmacogenes in the Spanish Population: From Genetic Characterisation to Clinical Impact. Pharmaceutics, 15(4), 1286.
https://doi.org/10.3390/pharmaceutics15041286
